
Guangdong Marubi Biotechnology Co., Ltd.
SSE:603983.SS
46.27 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 2,969.771 | 2,225.594 | 1,731.716 | 1,787.029 | 1,744.989 | 1,800.858 | 1,575.764 | 1,352.323 | 1,208.125 | 1,191.23 | 1,075.513 | 973.737 | 814.915 | 613.184 |
Kosten van de omzet
| 781.029 | 652.222 | 547.289 | 643.037 | 589.747 | 573.457 | 498.962 | 429.012 | 390.581 | 373.377 | 270.159 | 231.766 | 206.558 | 132.426 |
Brutowinst
| 2,188.742 | 1,573.372 | 1,184.428 | 1,143.992 | 1,155.242 | 1,227.4 | 1,076.802 | 923.312 | 817.544 | 817.853 | 805.354 | 741.971 | 608.357 | 480.758 |
Brutowinstmarge
| 0.737 | 0.707 | 0.684 | 0.64 | 0.662 | 0.682 | 0.683 | 0.683 | 0.677 | 0.687 | 0.749 | 0.762 | 0.747 | 0.784 |
Onderzoek- en ontwikkelingskosten
| 73.545 | 62.288 | 52.926 | 50.488 | 50.154 | 44.869 | 33.822 | 28.296 | 24.796 | 0 | 0 | 0 | 0 | 0 |
Algemene en administratieve kosten
| 42.599 | 42.31 | 42.534 | 39.825 | 33.351 | 45.104 | 28.055 | 29.568 | 21.785 | 84.326 | 87.189 | 60.881 | 41.893 | 32.528 |
Verkoop- en marketingkosten
| 1,518.191 | 1,105.548 | 846.157 | 741.295 | 564.099 | 540.451 | 534.591 | 466.95 | 472.277 | 419.753 | 404.858 | 423.488 | 345.973 | 240.339 |
Verkoop-, algemene en administratieve kosten
| 1,560.79 | 1,147.858 | 888.691 | 781.12 | 597.45 | 585.555 | 562.646 | 496.518 | 494.063 | 504.078 | 492.047 | 484.369 | 387.866 | 272.867 |
Overige kosten
| 173.47 | 43.89 | 69.363 | 62.124 | 20.151 | 25.532 | 2.127 | 0.59 | 13.198 | 16.391 | 12.639 | 10.883 | 7.842 | -1.591 |
Bedrijfskosten
| 1,807.805 | 1,240.984 | 1,010.98 | 893.732 | 667.755 | 655.955 | 622.067 | 575.013 | 571.785 | 519.563 | 506.372 | 497.449 | 399.008 | 282.435 |
Bedrijfsresultaat
| 380.937 | 319.337 | 207.337 | 298.991 | 572.525 | 612.648 | 484.172 | 366.055 | 260.309 | 313.668 | 306.143 | 249.802 | 212.797 | 201.452 |
Bedrijfsresultaat ratio
| 0.128 | 0.143 | 0.12 | 0.167 | 0.328 | 0.34 | 0.307 | 0.271 | 0.215 | 0.263 | 0.285 | 0.257 | 0.261 | 0.329 |
Totaal overige inkomsten en kosten netto
| -0.28 | -2.25 | -0.755 | 10.634 | -5.16 | 1.372 | 2.127 | 0.59 | 13.198 | 16.391 | 12.633 | 8.518 | 7.842 | -1.604 |
Inkomen voor belasting
| 380.657 | 317.086 | 206.581 | 309.625 | 567.365 | 614.021 | 486.299 | 366.644 | 273.507 | 330.059 | 318.777 | 258.32 | 220.639 | 199.848 |
Inkomen voor belasting ratio
| 0.128 | 0.142 | 0.119 | 0.173 | 0.325 | 0.341 | 0.309 | 0.271 | 0.226 | 0.277 | 0.296 | 0.265 | 0.271 | 0.326 |
Belastingkosten
| 38.293 | 39.497 | 39.15 | 68.433 | 103.969 | 101.201 | 74.257 | 54.725 | 41.318 | 48.625 | 47.402 | 39.705 | 33.781 | 32.59 |
Nettowinst
| 341.629 | 259.418 | 174.183 | 247.921 | 464.399 | 514.888 | 415.278 | 311.919 | 232.19 | 281.435 | 271.374 | 218.615 | 186.877 | 167.258 |
Nettowinstmarge
| 0.115 | 0.117 | 0.101 | 0.139 | 0.266 | 0.286 | 0.264 | 0.231 | 0.192 | 0.236 | 0.252 | 0.225 | 0.229 | 0.273 |
WPA (Winst Per Aandeel)
| 0.85 | 0.65 | 0.43 | 0.62 | 1.16 | 1.28 | 1.15 | 0.87 | 0.64 | 0.78 | 0.75 | 0.61 | 1.04 | 5.58 |
Verwaterde WPA
| 0.85 | 0.65 | 0.43 | 0.62 | 1.16 | 1.28 | 1.15 | 0.87 | 0.64 | 0.78 | 0.75 | 0.61 | 1.04 | 5.58 |
EBITDA
| 418.603 | 354.544 | 248.832 | 345.552 | 581.147 | 638.97 | 508.828 | 375.071 | 282.436 | 298.44 | 298.983 | 246.983 | 211.5 | 199.761 |
EBITDA ratio
| 0.141 | 0.159 | 0.144 | 0.193 | 0.333 | 0.355 | 0.323 | 0.277 | 0.234 | 0.251 | 0.278 | 0.254 | 0.26 | 0.326 |